Literature DB >> 8996162

Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.

L Guillou1, J M Coindre, F Bonichon, B B Nguyen, P Terrier, F Collin, M O Vilain, A M Mandard, V Le Doussal, A Leroux, J Jacquemier, H Duplay, X Sastre-Garau, J Costa.   

Abstract

PURPOSE: Several histologic grading systems have been validated in soft tissue sarcomas (STS), but no system is currently accepted worldwide. The National Cancer Institute (NCI) and French Federation of Cancer Centers Sarcoma Group (FNCLCC) systems were examined comparatively in the same population of patients with STS to determine which system is the best prognosticator with regard to metastasis development and tumor mortality. PATIENTS AND METHODS: Four hundred ten adult patients with nonmetastatic STS were examined. Histologic grade was established according to the NCI and FNCLCC systems in each case. The prognostic value of both systems was examined using univariate and multivariate (Cox's model) analyses, and special attention was devoted to tumors with discordant grades.
RESULTS: In univariate analysis, both the NCI and FNCLCC systems were of prognostic value to predict metastasis development and tumor mortality. In multivariate analysis, high-grade tumors, irrespective of the system used, size > or = 10 cm, and deep location were found to be independent prognostic factors for the advent of metastases. Tumor grade had a higher predictive value than size or depth, and higher prognostic weight was assigned to the FNCLCC grading system in Cox models. Grade discrepancies were observed in 34.6% of the cases. An increased number of grade 3 STS, a reduced number of grade 2 STS, and a better correlation with overall and metastasis-free survival within subpopulations with discordant grades were observed in favor of the FNCLCC system.
CONCLUSION: The FNCLCC system showed slightly increased ability to predict distant metastasis development and tumor mortality. The use of this system to evaluate STS aggressiveness might be favored.

Entities:  

Mesh:

Year:  1997        PMID: 8996162     DOI: 10.1200/JCO.1997.15.1.350

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  191 in total

1.  Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: correlation with histologic grading.

Authors:  Avneesh Chhabra; Oganes Ashikyan; Chenelle Slepicka; Nathan Dettori; Helena Hwang; Alexandra Callan; Rohit R Sharma; Yin Xi
Journal:  Eur Radiol       Date:  2018-12-03       Impact factor: 5.315

2.  Primary mediastinal sarcoma: surgical outcomes of 21 cases.

Authors:  Da-Xian Luo; Mei-Juan Huang; Bo Xiong; Tao Li; Ke Xie; Fu-Rong Chen; Guo-Wei Che; Jin Wang; Yong Xu; Xiao-Juan Zhou; You Lu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-11

3.  Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

Authors:  Christian Hagel; Ulrich Zils; Matthias Peiper; Lan Kluwe; Stefan Gotthard; Reinhard E Friedrich; David Zurakowski; Andreas von Deimling; Victor Felix Mautner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

4.  Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma.

Authors:  Lars Morawietz; Cornelius Kuhnen; Detlef Katenkamp; Philipp Le Coutre; Axel Ladhoff; Iver Petersen
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

Review 5.  The clinical management of chondrosarcoma.

Authors:  Richard F Riedel; Nicole Larrier; Leslie Dodd; David Kirsch; Salutario Martinez; Brian E Brigman
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

6.  PD-L1 and PD-1 and characterization of tumor-infiltrating lymphocytes in high grade sarcomas of soft tissue - prognostic implications and rationale for immunotherapy.

Authors:  Melanie Boxberg; Katja Steiger; Ulrich Lenze; Hans Rechl; Rüdiger von Eisenhart-Rothe; Klaus Wörtler; Wilko Weichert; Rupert Langer; Katja Specht
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

7.  Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.

Authors:  Sameer Yaser; Samer Salah; Marwa Al-Shatti; Areej Abu-Sheikha; Ahmad Shehadeh; Iyad Sultan; Ahmad Salem; Maher Sughayer; Shaymaa Al-Loh; Abdelatif Al-Mousa
Journal:  Med Oncol       Date:  2014-04-26       Impact factor: 3.064

8.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.

Authors:  Alex D Drilon; Sanjay Popat; Gauri Bhuchar; David R D'Adamo; Mary Louise Keohan; Cyril Fisher; Cristina R Antonescu; Samuel Singer; Murray F Brennan; Ian Judson; Robert G Maki
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

10.  Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.

Authors:  Janet F Eary; Finbarr O'Sullivan; Janet O'Sullivan; Ernest U Conrad
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.